文献速递颈动脉与弓上血管

术前颈动脉斑块回声透亮评估对CEA术后长期卒中或心血管死亡风险无预测价值

Pre-operative Carotid Plaque Echolucency Assessment has no Predictive Value for Long-Term Risk of Stroke or Cardiovascular Death in Patients Undergoing Carotid Endarterectomy.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2017-06-23

基于ACST-1试验中894例接受颈动脉内膜切除术并完成Gray-Weale视觉回声透亮评估的患者,51%斑块评为回声透亮。

要点

  • 术前斑块回声透亮不预测CEA围手术期死亡/卒中/心梗风险。
  • 回声透亮与10年任何卒中或心血管非卒中死亡风险无关。
  • Gray-Weale视觉评估在CEA患者中未显示预后价值。

核心结论

  • 在ACST-1中,CEA患者术前颈动脉斑块回声透亮评估对围手术期或长期卒中风险及心血管非卒中死亡无预测价值。

研究设计与样本

  • ACST-1试验中3120例患者有1832例接受CEA,其中894例按Gray-Weale分类完成视觉回声透亮评估。
  • 采用非条件最大似然估计计算围手术期风险比值比,Kaplan-Meier统计与对数秩检验比较长期累积风险。

临床怎么用

  • CEA术前常规视觉斑块回声透亮评估不宜用于预测围手术期或长期卒中及心血管死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In patients with carotid stenosis receiving medical treatment, carotid plaque echolucency has been thought to predict risk of future stroke and of other cardiovascular events. This study evaluated the prognostic value of pre-operative plaque echolucency for future stroke and cardiovascular death in patients undergoing carotid endarterectomy in the first Asymptomatic Carotid Surgery Trial (ACST-1). METHODS: In ACST-1, 1832/3120 patients underwent carotid endarterectomy (CEA), of whom 894 had visual echolucency assessment according to the Gray-Weale classification. During follow-up patients were monitored both for peri-procedural (i.e. within 30 days) death, stroke, or MI, and for long-term risk of stroke or cardiovascular death. Unconditional maximum likelihood estimation was used to calculate odds ratios of peri-procedural risk and Kaplan-Meier statistics with log-rank test were used to compare cumulative long-term risks. RESULTS: Of 894 operated patients in whom echolucency was assessed, 458 plaques (51%) were rated as echolucent and peri-procedural risk of death/stroke/MI in these patients was non-significantly higher when compared with patients with non-echolucent plaques (OR 1.48 [95% CI 0.76-2.88], p = .241). No differences were found in the 10 year risk of any stroke (30/447 [11.6%] vs. 29/433 [11.0%], p = .900) or cardiovascular (non-stroke) death (85/447 [27.9%] vs. 93/433 [32.1%], p = .301). CONCLUSION: In ACST-1, carotid plaque echolucency assessment in patients undergoing CEA offered no predictive value with regard to peri-operative or long-term stroke risk or of cardiovascular (non-stroke) death.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. de Waard D, de Borst GJ, Bulbulia R, et al. Pre-operative Carotid Plaque Echolucency Assessment has no Predictive Value for Long-Term Risk of Stroke or Cardiovascular Death in Patients Undergoing Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2017. PMID: 28651865. doi:10.1016/j.ejvs.2017.05.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。